| Not Yet Recruiting | Beta-lactam Plus Levofloxacin to Enhance Therapy in Streptococcal Septicemia NCT07240077 | Mahidol University | Phase 4 |
| Not Yet Recruiting | Impact of Blood Cultures Drawn From Arterial Lines on the Incidence of Contamination, Detection of Bacteremia, NCT07183410 | Meir Medical Center | — |
| Recruiting | Febrile Infants Swedish Study NCT07134751 | Region Skane | — |
| Not Yet Recruiting | Epidemiology of Antimicrobial-use and Antimicrobial-resistant Infections in Four Hospitals in Thailand NCT07082465 | University of Oxford | — |
| Recruiting | Echocardiography Versus no Echocardiography in S. Aureus Bacteraemia and VIRSTA Score < 3 NCT06457386 | Assistance Publique - Hôpitaux de Paris | N/A |
| Terminated | Combined Rehabilitation and Nutritional Support vs. Standard Care in In-Hospital Endocarditis Treatment NCT06563609 | Johannes Grand | N/A |
| Recruiting | Prospective Validation of GRADY: A Machine Learning Model for Early Sepsis and Bacteremia Detection in ICU Pat NCT07126106 | Sisli Hamidiye Etfal Training and Research Hospital | — |
| Enrolling By Invitation | Outcomes of Empiric Antibiotic Therapy Based on Hospital Antibiograms in Organ Transplant Recipients with Bact NCT06874920 | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | — |
| Recruiting | Surveillance of AMR in DRC NCT06821282 | University of Oxford | — |
| Recruiting | Improving Therapeutic Drug Monitoring and Dosing for Vancomycin in Young Infants With Infections (VANCAPP) (Pa NCT05770622 | Murdoch Childrens Research Institute | Phase 4 |
| Enrolling By Invitation | Knowledge Attitude and Practice Regarding Bloodstream Bacterial Infections and Antibiotics Usage Among Doctors NCT06605677 | Abu Dhabi Health Services Company | — |
| Recruiting | Impact of Performing a Rapid Antibiotic Susceptibility Test on Antibiotic Therapy Adaptation in Adult Patients NCT06425367 | Fondation Hôpital Saint-Joseph | N/A |
| Not Yet Recruiting | An Oral Doxycycline Regimen to Prevent Bacteremia Following Dental Procedures NCT06422221 | University of Santiago de Compostela | Phase 4 |
| Terminated | Anchoring Sequential Intermittent Long Acting Antimicrobials With Medication for Opioid Use Disorder (MOUD) fo NCT05521880 | University of Maryland, Baltimore | Phase 4 |
| Recruiting | Structural and Microbiological Characterization of Arterial Catheter Biofilm in ICU's Patients Using Optical C NCT06838598 | Centre Hospitalier William Morey - Chalon sur Saône | — |
| Completed | Mortality of MBL-producing Enterobacteriaceae Bacteremias with the Combined Use of Ceftazidime-avibactam and A NCT06419296 | Hospital Italiano de Buenos Aires | — |
| Recruiting | Evaluation of Emergency Medicine Pharmacist Impact on Blood Culture Review Following Emergency Department Disc NCT07486362 | Methodist Health System | — |
| Completed | Rapid Antimicrobial Susceptibility Testing with MIC Directly from Positive Blood Cultures with ASTar NCT06218277 | University Hospital, Ghent | N/A |
| Completed | NGS-Based Assay of Blood Samples of Sepsis Patients for Rapid Bacterial Identification NCT06141395 | Hellenic Institute for the Study of Sepsis | — |
| Unknown | Exposure to Antibiotics and Incidence of Bacteraemia Caused by Resistant Bacteria NCT04065750 | Assistance Publique - Hôpitaux de Paris | — |
| Completed | Medical Device (MD) Derived Pharmacokinetic (PK) Parameters for Vancomycin (MD-PK) NCT05950984 | St George's, University of London | — |
| Recruiting | Reducing Risk for Infective Endocarditis NCT05721781 | Wake Forest University Health Sciences | N/A |
| Recruiting | Pivmecillinam With Amoxicillin/Clavulanic Acid for Step Down Oral Therapy in ESBL UTIs NCT05224401 | Lund University | Phase 3 |
| Unknown | Treating Donors With Intravenous Immunoglobulin to Reduce Donor-Derived Infections NCT05799716 | Shanghai Changzheng Hospital | Phase 4 |
| Completed | Impact of BacT/Alert® VIRTUO®, BioFire® Blood Culture Identification 2-BCID2 and REVEAL® (bioMérieux) on the O NCT05741424 | Centre Hospitalier Universitaire de Nīmes | N/A |
| Terminated | Ceftolozane-Tazobactam for Directed Treatment of Pseudomonas Aeruginosa Bacteremia and Pneumonia in Patients W NCT04673175 | Weill Medical College of Cornell University | Phase 4 |
| Completed | How to Reduce Unnecessary Blood Cultures: Construction and Validation of a Predictive Score for Blood Culture NCT05686577 | University Hospital, Tours | — |
| Completed | Cefepime vs. Carbapenems for Treating AmpC β-lactamase-producing Enterobacteriaceae Bloodstream Infections NCT05535751 | University Hospital, Strasbourg, France | — |
| Unknown | Predictors of Infective Endocarditis Among Patients Managed for Staphylococcus Aureus Bacteremia, Particularly NCT05522764 | Fondation Hôpital Saint-Joseph | — |
| Withdrawn | PipEracillin/Tazobactam Versus mERoPENem for Treatment of AmpC Producing Blood Stream Infections NCT05355350 | Rambam Health Care Campus | Phase 4 |
| Completed | Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacterem NCT05184764 | Armata Pharmaceuticals, Inc. | Phase 1 / Phase 2 |
| Completed | Evaluation of Bacteremia Epidemiology During the COVID Period in One French University Hospital NCT05640349 | Centre Hospitalier Universitaire de Nice | — |
| Completed | Rapid Blood Culture Identification Panel in Pediatric Patients in Guatemala NCT05314816 | University of Colorado, Denver | N/A |
| Completed | Epidemiology of Bacteremia at Two Tertiary ICUs in Switzerland NCT05236283 | Insel Gruppe AG, University Hospital Bern | — |
| Terminated | Seven Versus 14 Days of Antibiotic Therapy for Multidrug-resistant Gram-negative Bacilli Infections NCT05210387 | Hospital Moinhos de Vento | N/A |
| Unknown | T2 and SeptiCyte RAPID Duration Project NCT04821661 | The University of Queensland | — |
| Unknown | Design of a Predictive Score for Contamination of Pediatric Blood Cultures NCT06300736 | Central Hospital, Nancy, France | — |
| Completed | Efficacy and Safety of CAZ-AVI in the Treatment of Infections Due to Carbapenem-resistant G- Pathogens in Chin NCT04882085 | Pfizer | Phase 4 |
| Active Not Recruiting | Monocyte Distribution Width (MDW) in the General Population of Emergency Department Patients With and Without NCT05296590 | Henry Ford Health System | — |
| Unknown | Intensive Care Unit Acquired Infections in Patients Colonized With Extended Spectrum Enterobacteriaceae NCT04903886 | University Hospital, Brest | — |
| Completed | Infectious Diseases in Aged Population NCT04825132 | University Hospital, Grenoble | N/A |
| Completed | Continuous Temperature Telemonitoring of Patients With COVID-19 and Other Infectious Diseases in Hospital at H NCT05959928 | Vitio Medical S.L. | — |
| Completed | Temocillin vs Meropenem for the Targeted Treatment of Bacteraemia Resistant to Third Gen Cephalosporins NCT04478721 | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | Phase 3 |
| Completed | Diagnostic Performance of Plasma Procalcitonin for the Detection of Blood Cultures Contaminations NCT04573894 | Central Hospital, Nancy, France | — |
| Unknown | Epidemiology and Determinants of Outcomes of Hospital Acquired Blood Stream Infections in the Intensive Care i NCT04304456 | SCARE (Study group for carbapenem resistance) | — |
| Completed | Host RNA Profiles to Detect Infections in Young Infants NCT04823026 | Rigshospitalet, Denmark | — |
| Completed | Clinical Performance and Reproducibility of the Accelerate PhenoTest™ Blood Culture (BC) Kit With New Antibiot NCT04295915 | Accelerate Diagnostics, Inc. | — |
| Unknown | Assessment of Assay for Rapid Identification of Bloodstream Infections From Whole Blood NCT04147975 | HelixBind, Inc. | — |
| Completed | Study to Evaluate the Efficacy and Safety of Intravenous Sulbactam-ETX2514 in the Treatment of Patients With I NCT03894046 | Entasis Therapeutics | Phase 3 |
| Completed | Safety of Acupuncture and Intracutaneous Needles in Pediatric Cancer Patients: a Retrospective Study (ACUSAFE2 NCT05585463 | Fundació Sant Joan de Déu | — |
| Completed | Improving Dosing of Vancomycin in Young Infants With Infections NCT04044703 | Murdoch Childrens Research Institute | Phase 4 |
| Completed | Epidemiology and Determinants of Outcomes of Hospital Acquired Blood Stream Infections in the Intensive Care NCT03937245 | Outcome Rea | — |
| Completed | Fast Assay for Pathogen Identification - Quasi-Experimental Intervention Study NCT04103203 | Hasselt University | N/A |
| Completed | Effect of Vitamin B12 on the Development of Sepsis, in Culture Positive Patients NCT04008446 | University of Zurich | — |
| Completed | Ertapenem for Initial Empirical Treatment of Third Generation Cephalosporin Resistant Enterobacteriaceae Bacte NCT03925402 | Phramongkutklao College of Medicine and Hospital | — |
| Recruiting | PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resis NCT03671967 | Rambam Health Care Campus | Phase 4 |
| Active Not Recruiting | Bacteremia From Periodontal Treatment to Elucidate the Underpinnings of Sepsis NCT04565691 | Malmö University | N/A |
| Completed | Fast Assay for Pathogen Identification and Characterization NCT03841162 | Hasselt University | — |
| Completed | Safety, Efficacy, and Pharmacokinetics (PK) of Daptomycin (MK-3009) in Japanese Pediatric Subjects With Compli NCT03643952 | Merck Sharp & Dohme LLC | Phase 2 |
| Completed | Empirical Antibiotic and Outcome in Community-onset Bacteremia NCT03765749 | Phramongkutklao College of Medicine and Hospital | — |
| Completed | Turkish Prospective Cohort Study on Carbapenem Resistant Klebsiella Pneumonia Bacteremia NCT03597841 | Koç University | — |
| Completed | Blood Culture Improvement Guidelines and Diagnostic Stewardship for Antibiotic Reduction in Critically Ill Chi NCT03441126 | Johns Hopkins University | — |
| Completed | Bloodstream Infection of Carbapenem-Resistant Proteus Mirabilis NCT06542965 | Dokuz Eylul University | — |
| Completed | Device for Bacteremia Prevention in Post Cardiac Surgical Intensive Care Unit Patients NCT03309137 | Alison Fox-Robichaud | N/A |
| Completed | Impact of the Blood Culture Technique on the Diagnosis of Infective Endocarditis NCT03153384 | Central Hospital, Nancy, France | — |
| Withdrawn | Therapeutic Drug Monitoring and Continuous Infusion of Beta-lactam Antibiotics in Patients With Bacteraemia NCT03108690 | Sara Thønnings | Phase 4 |
| Unknown | Amoxicillin to Prevent Bacteria and Inflammatory Biomarkers After Intensive Periodontal Therapy NCT03354338 | Universidad El Bosque, Bogotá | Phase 2 |
| Completed | Study to Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Participants With Staphylo NCT03162250 | Genentech, Inc. | Phase 1 |
| Terminated | Efficacy and Safety of Dalbavancin Compared to Standard of Care Antibiotic Therapy for the Completion of Treat NCT03148756 | AbbVie | Phase 2 |
| Unknown | Impact of Rapid Pathogen Identification From Blood Cultures (RABbIT) NCT02743585 | Tan Tock Seng Hospital | N/A |
| Completed | Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness NCT03005145 | Sunnybrook Health Sciences Centre | N/A |
| Unknown | C-reactive Protein Information and Blood Cultures for Emergency Department Patients With Sepsis NCT03714841 | University of British Columbia | N/A |
| Completed | Antibiotic "Dysbiosis" in Preterm Infants NCT02784821 | University of Florida | Phase 2 |
| Completed | Daptomycin as Adjunctive Therapy for Staphylococcus Aureus Bacteremia NCT02972983 | McGill University Health Centre/Research Institute of the McGill University Health Centre | Phase 4 |
| Recruiting | Fosfomycin I.v. for Treatment of Severely Infected Patients NCT02979951 | Infectopharm Arzneimittel GmbH | — |
| Unknown | Childhood Acute Illness and Nutrition Network NCT03208725 | University of Oxford | — |
| Completed | BALANCE on the Wards: A Pilot RCT NCT02917551 | Sunnybrook Health Sciences Centre | N/A |
| Completed | Spanish Bacteriemia Cohort 2016: Epidemiology, Clinical Management and Prognosis Factors NCT03148769 | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | — |
| Completed | Diagnosis of Bacteremia/Septicemia and Culture Negative Endocarditis by the Karius Sequencing-Based Infectious NCT02988414 | Karius, Inc. | — |
| Completed | Empirical ANtibiotic THErapy in Adults Hospitalised With Malaria NCT03224052 | Menzies School of Health Research | — |
| Completed | Safety Evaluation of Seraph® 100 to Reduce Bacteremia in Patients on Hemodialysis NCT02914132 | ExThera Medical Corporation | N/A |
| Terminated | Preventing Catheter-related Bacteremia When Administering Injectable Medications in Premature Infants. NCT02633124 | University Hospital, Lille | N/A |
| Completed | Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to ESBL- or Carb NCT02852902 | Spanish Network for Research in Infectious Diseases | — |
| Completed | Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture NCT02719769 | Accelerate Diagnostics, Inc. | — |
| Completed | T2Bacteria Panel Pivotal Study NCT02535468 | T2 Biosystems | — |
| Completed | IL-10 Stratifying Tool for Towards Antibiotic Selection for MRSaB NCT02660346 | Sharp HealthCare | Phase 4 |
| Completed | Effect of Supplementation of Fluoride on Maternal Periodontal Health, Preterm Delivery, and Perinatal Well-Bei NCT02536352 | Johns Hopkins University | EARLY_Phase 1 |
| Withdrawn | Factors Associated With Increased Risk of Bacteremia and Cholangitis in ERCP With Cholangioscopy NCT02543957 | Baylor College of Medicine | — |
| Completed | Ultra Rapid Culture Independent Detection of High-Priority Carbapenem Resistant Enterobacteriaceae Directly Fr NCT02482051 | Denver Health and Hospital Authority | — |
| Terminated | Procalcitonin Levels as a Predictor of Bacteremia in Febrile Pediatric Oncology Patients-Pilot Study NCT02417168 | CAMC Health System | — |
| Completed | Home Away From Home - Medical Outcomes NCT02774850 | Children's Hospital of Philadelphia | — |
| Withdrawn | Randomized-controlled Trial (RCT) on Combination Antibiotic for Infections Caused by Gram-negative Bacteria NCT02134106 | Tan Tock Seng Hospital | Phase 2 / Phase 3 |
| Terminated | A Phase 3 Telavancin Staphylococcus Aureus (S. Aureus) Bacteremia Trial NCT02208063 | Cumberland Pharmaceuticals | Phase 3 |
| Completed | Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness: A Pilot RCT NCT02261506 | Sunnybrook Health Sciences Centre | N/A |
| Completed | RCT of Continuous Versus Intermittent Infusion of Vancomycin in Neonates NCT02210169 | Murdoch Childrens Research Institute | N/A |
| Completed | Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections i NCT02168946 | Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) | Phase 3 |
| Completed | Study of Cases of Serious Infections Due to Carbapenem-Resistant Enterobacteriaceae NCT02420366 | Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) | — |
| Completed | Antibiotic Administration and Blood Culture Positivity in Severe Sepsis and Septic Shock NCT01867905 | University of British Columbia | — |
| Completed | Prospective Study to Characterize Host-pathogen Related Factors in Hospitalized and ED Patients With LRTI and/ NCT02025699 | MeMed Diagnostics Ltd. | — |
| Completed | A New Antibiotic Prophylaxis Regimen to Prevent Bacteremia Following Dental Procedures NCT02115776 | University of Santiago de Compostela | N/A |
| Completed | Virulence of Staphylococcus Lugdunensis in Severe Infections NCT02026895 | University Hospital, Strasbourg, France | N/A |
| Completed | Rapid Identification and Susceptibility Testing of Pathogens From Blood Cultures NCT01898208 | Mayo Clinic | N/A |
| Completed | Detecting Infections Rapidly and Easily for Bacteremia Trial (DIREBT) NCT01919762 | T2 Biosystems | — |
| Unknown | Simplified Selective Digestive Tract Decontamination for the Prevention of Intensive Care Unit Acquired Infect NCT01798537 | Rambam Health Care Campus | Phase 2 / Phase 3 |
| Unknown | Vancomycin Versus Ceftaroline in Patients With Infections Caused by MRSA That Are Susceptible to Ceftaroline NCT01724671 | CPL Associates | — |
| Completed | Safety & Efficacy of Daptomycin Versus Standard of Care (SOC) in 1 - 17 Year Olds With Staphylococcus Aureus B NCT01728376 | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Phase 4 |
| Completed | Immune Response of Patients With Chronic, Staphylococcus Aureus-infected Wounds NCT01551667 | Centre Hospitalier Universitaire de Nīmes | — |
| Completed | Blood Cultures's Profitability in Intensive Care Unit NCT02869191 | Hospital Universitario Getafe | — |
| Terminated | Study of the Performance of the KeyPath MRSA/MSSA Blood Culture Test - BTA NCT01640886 | MicroPhage, Inc. | — |
| Unknown | Concentration of Antimicrobials in Catheter-lock Solutions NCT01592032 | Clinica Universidad de Navarra, Universidad de Navarra | Phase 4 |
| Completed | Hub Cleansing to Prevent Hub Infection NCT01563406 | Rush University Medical Center | N/A |
| Completed | Evaluation in the Treatment of Nosocomial Sepsis Comparing Polymerase Chain Reaction With Conventional Blood C NCT01450358 | Instituto do Coracao | Phase 4 |
| Completed | Efficacy of 2% Chlorhexidine Gluconate in 70% Alcohol Compare 10% Povidone Iodine in Blood Culture in Children NCT01919593 | Thammasat University | Phase 4 |
| Terminated | Safety and Efficacy of Strategy to Prevent Drug-Induced Nephrotoxicity in High-Risk Patients NCT01734694 | Henry Ford Health System | Phase 4 |
| Completed | Efficacy and Safety of an Ethanol/Sodium Citrate Locking Solution: A Pilot Study NCT01394458 | University of Manitoba | N/A |
| Completed | Multicenter Blood Culture Quality Improvement NCT01413555 | Vanderbilt University | N/A |
| Unknown | Recurrent ESBL-producing Enterobacteriaceae Bacteremia: Risk Factor, Molecular Character and Susceptibility Ch NCT01392118 | Chang Gung Memorial Hospital | — |
| Terminated | Vancomycin Versus Daptomycin for the Treatment of Methicillin-resistant Staphylococcus Aureus Bacteremia Due t NCT01287832 | St. John Health System, Michigan | Phase 4 |
| Completed | Study to Evaluate the Safety and Efficacy of Telavancin in the Treatment of Gram Positive Bloodstream Infectio NCT01321879 | M.D. Anderson Cancer Center | Phase 2 |
| Unknown | Retrospective Evaluation of Safety and Efficacy of Daptomycin Used in Patients With Serious Gram-positive Infe NCT01301638 | Far Eastern Memorial Hospital | — |
| Completed | Treatment Algorithm to Reduce the Use of Vancomycin in Adults With Blood Stream Infection NCT01191840 | Duke University | Phase 2 |
| Completed | Epidemiologic Patterns of Bacteremia After Trauma NCT04042636 | Asan Medical Center | — |
| Unknown | Comparison of Nephrotoxicity and Hospital Costs in Patients With Methicillin-Resistant Staphylococcus Aureus B NCT01352936 | Taipei Medical University WanFang Hospital | — |
| Completed | Bacteraemia Secondary to Tooth Extraction: Chlorhexidine Prophylaxis Protocols NCT02150031 | University of Santiago de Compostela | Phase 4 |
| Unknown | Establish Quantitative PCR to Measure Bacteria Load of the VRE Bacteremia NCT01265095 | National Taiwan University Hospital | — |
| Completed | Clinical Evaluation of Novel Biomarkers in Patients With Septicemia NCT01359891 | Medical University of Graz | — |
| Completed | Incidence of Bacteremia Following Argon Plasma Coagulation in Patients With Endobronchial Lesions NCT01179022 | Meir Medical Center | — |
| Unknown | Ethanol Lock for the Salvage of Infected Long-term Vascular Access NCT01186172 | Fondazione IRCCS Policlinico San Matteo di Pavia | Phase 3 |
| Unknown | Daptomycin Pharmacokinetics in Continuous Veno-venous Hemodiafiltration NCT01171547 | University of Zurich | Phase 2 |
| Terminated | Safety and Efficacy Study of Ethanol Locking to Prevent Central Line Infection in Premature Neonates NCT01365312 | East Carolina University | N/A |
| Completed | Increasing the Yield of Blood Cultures in Neonates NCT01023555 | Shaare Zedek Medical Center | N/A |
| Completed | Comparison of Infection Rates Among Patients Using Two Catheter Access Devices NCT00965198 | Emory University | — |
| Completed | The Value of sTREM-1, PCT, and CRP as Markers for the Detection of Sepsis and Bacteremia Among Patients With a NCT01410578 | Chinese PLA General Hospital | — |
| Terminated | Prevalence of CVC-associated Sepsis and Use of Blood Cultures in Berlin - Brandenburg NCT01388686 | Charite University, Berlin, Germany | — |
| Completed | Prospective Study Into the Performance of the MicroPhage S. Aureus/MSSA/MRSA Test Direct From Blood Culture Po NCT01184339 | MicroPhage, Inc. | — |
| Unknown | Central Venous Catheter Lock Solution NCT00862966 | University Medical Center, Tuzla | N/A |
| Completed | Effectiveness of Routine Sterile Gloving in Blood Culture NCT00973063 | Seoul National University Hospital | N/A |
| Withdrawn | A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Bacteremia Due to S. Epidermidis NCT00509847 | AM-Pharma | Phase 1 / Phase 2 |
| Terminated | Validation Study of Combined Positron Emission Tomography/Computer Tomography to Diagnose Infection and Inflam NCT00835783 | Odense University Hospital | — |
| Completed | The Impact of Material on Microbiota in Association With Tongue and Lip Piercing NCT01039259 | Medical University Innsbruck | — |
| Completed | Procalcitonin Level and Kinetics in Children With Bacterial Infections NCT00714402 | Shaare Zedek Medical Center | — |
| Completed | MicroPhage S. Aureus / MSSA / MRSA Blood Culture Beta Trial NCT00814151 | MicroPhage, Inc. | — |
| Completed | Optimizing Dosing of Colistin for Infections Resistant to All Other Antibiotics, Approved NIH Protocol Dated 1 NCT00235690 | University of Pittsburgh | N/A |
| Completed | A Cluster-randomized Cross-over Trial Evaluating the Comparative Effectiveness of Three Skin Antiseptic Interv NCT01216761 | University of Michigan | N/A |
| Completed | Taurolidine Lock Solution in the Prevention of Catheter Related Bacteremia NCT00735813 | Aarhus University Hospital | Phase 3 |
| Completed | Rapid Test to Detect Staphylococcus Aureus in Blood and Wound Infections NCT01198262 | Michael E. DeBakey VA Medical Center | — |
| Unknown | UGIST: Ultrasound Guided Internal Jugular Short-Term Central Venous Catheters Tunneling NCT00639197 | Hamilton Health Sciences Corporation | N/A |
| Terminated | Efficacy, Immunogenicity, and Safety of a Single Dose of V710 in Adult Patients Scheduled for Cardiothoracic S NCT00518687 | Merck Sharp & Dohme LLC | Phase 2 / Phase 3 |
| Completed | Piperacillin/Tazobactam for Bacteremia With Organisms Producing Chromosomally-Encoded AmpC Beta-Lactamase NCT00414193 | University of Pittsburgh | — |
| Completed | Clinical Impact of Fluoroquinolone Resistance in Bacteremia Caused by Gram-Negative Bacilli of Urinary Tract O NCT00414362 | University of Pittsburgh | — |
| Completed | Dressing: Frequency of Change and Evaluation of an Antiseptic-Impregnated Catheter Dressing in ICU Patients NCT00417235 | University Hospital, Grenoble | Phase 4 |
| Completed | Impact of Procalcitonin on the Management of Children Aged 1 to 36 Month Presenting With a Fever Without a Sou NCT00692848 | St. Justine's Hospital | N/A |
| Terminated | Steady State Serum and Epithelial Lining Fluid (ELF) Antibiotics Concentrations Under Continous Infusion NCT00435305 | University Hospital Tuebingen | — |
| Unknown | Infections Caused by ESbL-Producing Enterobacteriaceae in Italy NCT00404625 | University of Siena | — |
| Completed | Moxifloxacin in the Prevention of Bacteremia After High-dose Chemotherapy and Transplantation of Peripheral St NCT00398411 | University of Cologne | Phase 3 |
| Completed | Efficacy of Cefepime Continuous Infusion Versus an Intermittent Dosing Regimen NCT00609375 | Javeriana University | Phase 4 |
| Terminated | Colombia Epidemiologic Surveillance Study NCT00428051 | Pfizer | — |
| Terminated | Concentrated Citrate Locking to Reduce the Incidence of CVC-related Complications in Hematological Patients NCT01820962 | Maastricht University Medical Center | Phase 3 |
| Terminated | The Role of Synbiotics in Reducing Post-Operative Infections in Patients Undergoing Cardiac Surgery: A Pilot S NCT00164099 | Beth Israel Medical Center | Phase 4 |
| Recruiting | Lebanese Interhospital Pneumococcal Surveillance Program NCT00901602 | American University of Beirut Medical Center | — |
| Terminated | Linezolid in the Treatment of Hemodialysis Patients With Catheter-Related Gram-Positive Bloodstream Infections NCT00108433 | Pfizer | Phase 3 |
| Completed | Pharmacodynamic Parameters of Two Different Doses of Cefepime NCT00177736 | University of Pittsburgh | — |
| Completed | Alcohol Locks for the Prevention of Tunneled Catheter-related Infections NCT00122642 | Erasmus Medical Center | Phase 2 / Phase 3 |
| Completed | Skin Cleansing With Chlorhexidine to Decrease Hospital Acquired Infections NCT00130221 | Cook County Health | Phase 1 |
| Completed | Virulence Determinants in S Aureus Bacteremia NCT00319826 | Duke University | — |
| Completed | Prophylactic Antimicrobial Catheter Lock NCT00571259 | Satellite Healthcare | Phase 4 |
| Completed | Bacteria Entering the Blood Stream From Tooth Extractions and Tooth Brushing NCT00454285 | Wake Forest University Health Sciences | Phase 2 |
| Completed | Prevention of Catheter-Associated Infection With the Skin Disinfectant Octenidine Dihydrochloride NCT00515151 | University Hospital Freiburg | Phase 4 |
| Completed | Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive Bacteria NCT00037050 | Pfizer | Phase 3 |
| Completed | Daptomycin in the Treatment of Subjects With Infective Endocarditis or Bacteremia Due to S. Aureus NCT00093067 | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Phase 3 |
| Completed | Clinical Outcomes and Cost of Gram Negative Bacteremia NCT02599220 | Duke University | — |
| Unknown | Safety and Efficacy of Dalbavancin Versus Vancomycin in the Treatment of Catheter-Related Bloodstream Infectio NCT00057369 | Vicuron Pharmaceuticals | Phase 2 |
| Completed | Safety and Efficacy of MBI 226 for the Prevention of Central Venous Catheter-Related Bloodstream Infections NCT00027248 | BioWest Therapeutics Inc | Phase 3 |
| Completed | Combination Therapy With Fluoroquinolone in Staphylococcus Aureus Bacteremia NCT00548002 | University of Helsinki | — |
| Completed | Impact of Continuous Venovenous Haemofiltration on Organ Failure During the Early Phase of Severe Sepsis NCT00406198 | Hopital Lariboisière | Phase 4 |
| Withdrawn | Ceftobiprole in the Treatment of Hospitalized Patients With Staphylococcus Aureus Bacteremia NCT00505258 | Basilea Pharmaceutica | Phase 2 |
| No Longer Available | Personalized Phage Treatment in Covid-19 Patients With Bacterial Co-Infections Microbials for Pneumonia or Bac NCT04636554 | Adaptive Phage Therapeutics, Inc. | — |
| Terminated | Prevention of Bacteremia Induced by Debridement of Pressure Ulcer NCT00269100 | Herzog Hospital | — |